Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial is a clinical trial[1].
Key Facts
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial is in the country of United States[2].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's instance of is recorded as clinical trial[3].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's start time is recorded as +2011-09-30T00:00:00Z[4].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's end time is recorded as +2020-12-31T00:00:00Z[5].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's sponsor is recorded as Northwestern University[6].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's number of participants is recorded as {'unit': '1', 'amount': '+80'}[7].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's title is recorded as Randomized Study of Different Non-myeloablative Conditioning Regimens With Hematopoietic Stem Cell Support in Patients With Scleroderma (Autologous Systemic Sclerosis Immune Suppression Trial - II ASSIST-IIb)[8].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's short name is recorded as DIScl2011[9].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+17'}[10].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's ClinicalTrials.gov ID is recorded as NCT01445821[11].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}[12].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as (RS)-cyclophosphamide[13].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as fludarabine phosphate[14].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as anti-thymocyte globulin (rabbit)[15].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as methylprednisolone hemisuccinate[16].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as lenograstim[17].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as methylprednisolone[18].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as methylprednisolone acetate[19].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as prednisolone acetate[20].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as prednisolone hemisuccinate[21].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as prednisolone 21-phosphate[22].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as prednisolone[23].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research intervention is recorded as mesna[24].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's clinical trial phase is recorded as phase III clinical trial[25].
- Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial's research site is recorded as Northwestern University[26].